New England Journal of Medicine
2014-10-02
Exemestane with ovarian suppression in premenopausal breast cancer.
Vito Amoroso, Alfredo Berruti, Edda Simoncini
Index: N. Engl. J. Med. 371(14) , 1357, (2014)
Full Text: HTML
Abstract
Related Articles:
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
2015-01-02
[Oncogene 34(1) , 27-38, (2015)]
Comparison of tamoxifen and letrozole response in mammary preneoplasia of ER and aromatase overexpressing mice defines an immune-associated gene signature linked to tamoxifen resistance.
2015-01-01
[Carcinogenesis 36(1) , 122-32, (2015)]
Exposure to the polyester PET precursor--terephthalic acid induces and perpetuates DNA damage-harboring non-malignant human breast cells.
2015-01-01
[Carcinogenesis 36(1) , 168-76, (2015)]
Chronic centrosome amplification without tumorigenesis.
2015-11-17
[Proc. Natl. Acad. Sci. U. S. A. 112 , E6321-30, (2015)]
Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats.
2014-12-01
[Toxicol. Pathol. 42(8) , 1188-96, (2014)]